Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Pharm Biomed Anal. 2013 Aug 29;88:180–190. doi: 10.1016/j.jpba.2013.08.024

Table 2.

Intra-day precision analysis for absolute quantification of human UGT1A1. Two batches of pooled, individual HLMs and UGT1A1 Supersomes™ were used in the determinations (n=3).

UGT1A1 (pmol/mg Protein)
Peptide 1 Peptide 2
MRM1 MRM2 MRM1 MRM2
Batch 1 pHLM Average 9.9 12.2 11.0 13.5
% C.V. 1.5 1.0 1.0 0.4
Supersome™ Average 179.0 180.2 175.6 198.6
% C.V. 3.4 1.6 1.0 2.0
HLM 442 Average 5.6 8.1 8.6 9.9
% C.V. 5.0 2.2 1.2 2.6
HLM 743 Average 18.4 20.5 22.5 26.2
% C.V. 3.7 4.2 3.3 5.4
HLM 751 Average 18.4 20.8 20.1 23.9
% C.V. 2.7 0.8 1.5 2.0
Batch 2 pHLM Average 8.6 9.0 3.1 5.1
% C.V. 4.4 2.0 3.3 3.8
Supersome™ Average 170.0 176.6 100.4 111.4
% C.V. 3.4 1.6 1.0 2.0
HLM442 Average 4.6 4.8 1.6 3.1
% C.V. 5.8 3.6 3.9 4.8
HLM 743 Average 16.8 17.2 9.7 12.2
% C.V. 3.9 5.0 4.5 6.6
HLM 751 Average 17.5 18.0 8.6 11.3
% C.V. 2.7 0.9 2.1 2.4